{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:05:10Z","timestamp":1788818710317,"version":"build-2803163510"},"reference-count":262,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00432-023-05144-9","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T08:01:45Z","timestamp":1692086505000},"page":"15249-15273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recent advances and applications of peptide\u2013agent conjugates for targeting tumor cells"],"prefix":"10.1007","volume":"149","author":[{"given":"Vahab","family":"Alamdari-palangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khojaste Rahimi","family":"Jaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Shahverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Naeimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Tajbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Khajeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Razban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"5144_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2683286","volume":"2020","author":"MI Abdelmageed","year":"2020","unstructured":"Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW, Makhawi AM (2020) Design of a multiepitope-based peptide vaccine against the E protein of human COVID-19: an immunoinformatics approach. BioMed Res Int 2020:1\u201312","journal-title":"BioMed Res Int"},{"key":"5144_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00280-009-1232-1","volume":"66","author":"S Ackler","year":"2010","unstructured":"Ackler S, Mitten MJ, Foster K, Oleksijew A, Refici M, Tahir SK, Xiao Y, Tse C, Frost DJ et al (2010) The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo. Cancer Chemother Pharmacol 66:869\u2013880. https:\/\/doi.org\/10.1007\/s00280-009-1232-1","journal-title":"Cancer Chemother Pharmacol"},{"key":"5144_CR3","doi-asserted-by":"publisher","first-page":"19249","DOI":"10.1002\/ange.201911900","volume":"131","author":"V Adebomi","year":"2019","unstructured":"Adebomi V, Cohen RD, Wills R, Chavers HAH, Martin GE, Raj M (2019) CyClick chemistry for the synthesis of cyclic peptides. Angew Chem 131:19249\u201319256","journal-title":"Angew Chem"},{"key":"5144_CR179","doi-asserted-by":"publisher","unstructured":"Adis R&D Profile (2005) Histrelin hydrogel implant\u2013valera: Histrelin implant, LHRH-Hydrogel implant, RL 0903, SPD 424. Drugs R D 6:53\u201355. https:\/\/doi.org\/10.2165\/00126839-200506010-00007","DOI":"10.2165\/00126839-200506010-00007"},{"key":"5144_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1200\/jco.22.00096","volume":"41","author":"O Adot\u00e9vi","year":"2023","unstructured":"Adot\u00e9vi O, Vernerey D, Jacoulet P, Meurisse A, Laheurte C, Almotlak H, Jacquin M, Kaulek V, Boullerot L et al (2023) Safety, immunogenicity, and 1-year efficacy of universal cancer peptide-based vaccine in patients with refractory advanced non-small-cell lung cancer: a phase Ib\/phase IIa de-escalation study. J Clin Oncol 41:373\u2013384. https:\/\/doi.org\/10.1200\/jco.22.00096","journal-title":"J Clin Oncol"},{"key":"5144_CR5","doi-asserted-by":"publisher","first-page":"bbaa153","DOI":"10.1093\/bib\/bbaa153","volume":"22","author":"P Agrawal","year":"2021","unstructured":"Agrawal P, Bhagat D, Mahalwal M, Sharma N, Raghava GP (2021) AntiCP 2.0: an updated model for predicting anticancer peptides. Brief Bioinform 22:bbaa153","journal-title":"Brief Bioinform"},{"key":"5144_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","volume":"64","author":"M Alas","year":"2020","unstructured":"Alas M, Saghaeidehkordi A, Kaur K (2020) Peptide\u2013drug conjugates with different linkers for cancer therapy. J Med Chem 64:216\u2013232","journal-title":"J Med Chem"},{"key":"5144_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.peptides.2012.03.023","volume":"36","author":"AM Alizadeh","year":"2012","unstructured":"Alizadeh AM, Faghihi M, Khori V, Sohanaki H, Pourkhalili K, Mohammadghasemi F, Mohsenikia MJP (2012) Oxytocin protects cardiomyocytes from apoptosis induced by ischemia\u2013reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore. Peptides 36:71\u201377","journal-title":"Peptides"},{"key":"5144_CR8","doi-asserted-by":"publisher","first-page":"8483","DOI":"10.1007\/s13277-014-2421-z","volume":"35","author":"AM Alizadeh","year":"2014","unstructured":"Alizadeh AM, Shiri S, Farsinejad S (2014) Metastasis review: from bench to bedside. Tumour Biol 35:8483\u20138523. https:\/\/doi.org\/10.1007\/s13277-014-2421-z","journal-title":"Tumour Biol"},{"key":"5144_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1615\/CritRevImmunol.v14.i3-4.40","volume":"14","author":"V Apostolopoulos","year":"1994","unstructured":"Apostolopoulos V, McKenzie IF (1994) Cellular mucins: targets for immunotherapy. Crit Rev Immunol 14:293","journal-title":"Crit Rev Immunol"},{"key":"5144_CR10","doi-asserted-by":"crossref","unstructured":"Apostolopoulos V, Bojarska J, Chai T-T, Feehan J, Kaczmarek K, Matsoukas JM, Paredes Lopez O, Saviano M, Skwarczynski M et al (2022a) New advances in short peptides: looking forward, vol 27. In: MDPI, p 3635","DOI":"10.3390\/molecules27113635"},{"key":"5144_CR11","doi-asserted-by":"publisher","first-page":"914467","DOI":"10.3389\/fphar.2022.914467","volume":"13","author":"V Apostolopoulos","year":"2022","unstructured":"Apostolopoulos V, Bojarska J, Feehan J, Matsoukas J, Wolf W (2022b) Smart therapies against global pandemics: a potential of short peptides. Front Pharmacol 13:914467","journal-title":"Front Pharmacol"},{"key":"5144_CR12","doi-asserted-by":"publisher","first-page":"863234","DOI":"10.3389\/fimmu.2022.863234","volume":"13","author":"Y Araf","year":"2022","unstructured":"Araf Y, Moin AT, Timofeev VI, Faruqui NA, Saiara SA, Ahmed N, Parvez MSA, Rahaman TI, Sarkar B et al (2022) Immunoinformatic design of a multivalent peptide vaccine against mucormycosis: targeting FTR1 protein of major causative fungi. Front Immunol 13:863234","journal-title":"Front Immunol"},{"key":"5144_CR13","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1093\/emboj\/cdg423","volume":"22","author":"D Arnoult","year":"2003","unstructured":"Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F, Youle RJ (2003) Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax\/Bak-mediated permeabilization. EMBO J 22:4385\u20134399","journal-title":"EMBO J"},{"key":"5144_CR14","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1021\/bi011549t","volume":"41","author":"D Avrahami","year":"2002","unstructured":"Avrahami D, Shai Y (2002) Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. Biochemistry 41:2254\u20132263","journal-title":"Biochemistry"},{"key":"5144_CR15","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.imbio.2012.12.002","volume":"218","author":"S Bae","year":"2013","unstructured":"Bae S, Oh K, Kim H, Kim Y, Kim HR, Hwang YI, Lee DS, Kang JS, Lee WJ (2013) The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin\/granzyme B secretion. Immunobiology 218:1026\u20131033. https:\/\/doi.org\/10.1016\/j.imbio.2012.12.002","journal-title":"Immunobiology"},{"key":"5144_CR16","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1016\/j.bmc.2016.12.046","volume":"25","author":"P Bana","year":"2017","unstructured":"Bana P, \u00d6rk\u00e9nyi R, L\u00f6vei K, Lak\u00f3 \u00c1, T\u00far\u00f3s GI, \u00c9les J, Faigl F, Greiner I (2017) The route from problem to solution in multistep continuous flow synthesis of pharmaceutical compounds. Biorg Med Chem 25:6180\u20136189","journal-title":"Biorg Med Chem"},{"key":"5144_CR17","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1158\/1078-0432.CCR-18-3997","volume":"25","author":"T Bekaii-Saab","year":"2019","unstructured":"Bekaii-Saab T, Wesolowski R, Ahn DH, Wu C, Mortazavi A, Lustberg M, Ramaswamy B, Fowler J, Wei L et al (2019) Phase I immunotherapy trial with two chimeric HER-2 B-cell peptide vaccines emulsified in montanide ISA 720VG and nor-MDP adjuvant in patients with advanced solid tumors phase I immunotherapy trial with two B-cell vaccines. Clin Cancer Res 25:3495\u20133507","journal-title":"Clin Cancer Res"},{"key":"5144_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.biocel.2009.11.013","volume":"42","author":"NC Bennett","year":"2010","unstructured":"Bennett NC, Gardiner RA, Hooper JD, Johnson DW, Gobe GC (2010) Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol 42:813\u2013827","journal-title":"Int J Biochem Cell Biol"},{"key":"5144_CR19","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.2174\/15680266113136660226","volume":"13","author":"JB Bhonsle","year":"2013","unstructured":"Bhonsle JB, Clark T, Bartolotti L, Hicks RP (2013) A brief overview of antimicrobial peptides containing unnatural amino acids and ligand-based approaches for peptide ligands. Curr Top Med Chem 13:3205\u20133224","journal-title":"Curr Top Med Chem"},{"key":"5144_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/pharmaceutics15020452","volume":"15","author":"B Biri-Kov\u00e1cs","year":"2023","unstructured":"Biri-Kov\u00e1cs B, B\u00e1n\u00f3czi Z, Tummalapally A, Szab\u00f3 I (2023) Peptide vaccines in melanoma: chemical approaches towards improved immunotherapeutic efficacy. Pharmaceutics 15:452","journal-title":"Pharmaceutics"},{"key":"5144_CR21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3390\/biom11101515","volume":"11","author":"J Bojarska","year":"2021","unstructured":"Bojarska J, Mieczkowski A, Ziora ZM, Skwarczynski M, Toth I, Shalash AO, Parang K, El-Mowafi SA, Mohammed EH et al (2021) Cyclic dipeptides: the biological and structural landscape with special focus on the anti-cancer proline-based scaffold. Biomolecules 11:1515","journal-title":"Biomolecules"},{"key":"5144_CR22","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.2174\/092986712801661004","volume":"19","author":"RJ Boohaker","year":"2012","unstructured":"Boohaker RJ, Lee MW, Vishnubhotla P, Perez JLM, Khaled AR (2012) The use of therapeutic peptides to target and to kill cancer cells. Curr Med Chem 19:3794\u20133804","journal-title":"Curr Med Chem"},{"key":"5144_CR23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"5144_CR24","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s10529-014-1642-y","volume":"36","author":"MJ Calcott","year":"2014","unstructured":"Calcott MJ, Ackerley DF (2014) Genetic manipulation of non-ribosomal peptide synthetases to generate novel bioactive peptide products. Biotechnol Lett 36:2407\u20132416","journal-title":"Biotechnol Lett"},{"key":"5144_CR25","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0169-409X(03)00108-X","volume":"55","author":"P Caliceti","year":"2003","unstructured":"Caliceti P, Veronese FM (2003) Pharmacokinetic and biodistribution properties of poly (ethylene glycol)\u2013protein conjugates. Adv Drug Del Rev 55:1261\u20131277","journal-title":"Adv Drug Del Rev"},{"key":"5144_CR26","doi-asserted-by":"publisher","first-page":"2054305","DOI":"10.1080\/2162402X.2022.2054305","volume":"11","author":"KM Calvillo-Rodr\u00edguez","year":"2022","unstructured":"Calvillo-Rodr\u00edguez KM, Mendoza-Reveles R, G\u00f3mez-Morales L, Uscanga-Palomeque AC, Karoyan P, Mart\u00ednez-Torres AC, Rodr\u00edguez-Padilla C (2022) PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells. Oncoimmunology 11:2054305","journal-title":"Oncoimmunology"},{"key":"5144_CR27","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1039\/D2CP03528F","volume":"25","author":"M Campanile","year":"2023","unstructured":"Campanile M, Oliva R, D\u2019Errico G, Del Vecchio P, Petraccone L (2023) The anticancer peptide LL-III alters the physico-chemical properties of a model tumor membrane promoting lipid bilayer permeabilization. PCCP 25:3639","journal-title":"PCCP"},{"key":"5144_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1039\/B807871H","volume":"39","author":"LA Canalle","year":"2010","unstructured":"Canalle LA, L\u00f6wik DW, van Hest JC (2010) Polypeptide\u2013polymer bioconjugates. Chem Soc Rev 39:329\u2013353","journal-title":"Chem Soc Rev"},{"key":"5144_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1073\/pnas.032427999","volume":"99","author":"E Carafoli","year":"2002","unstructured":"Carafoli E (2002) Calcium signaling: a tale for all seasons. Proc Natl Acad Sci 99:1115\u20131122","journal-title":"Proc Natl Acad Sci"},{"key":"5144_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","volume":"157","author":"P Chames","year":"2009","unstructured":"Chames P, Van Regenmortel M, Weiss E, Baty D (2009) Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 157:220\u2013233. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00190.x","journal-title":"Br J Pharmacol"},{"key":"5144_CR31","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1158\/1078-0432.CCR-20-2275","volume":"27","author":"E Chang","year":"2021","unstructured":"Chang E, Weinstock C, Zhang L, Charlab R, Dorff SE, Gong Y, Hsu V, Li F, Ricks TK et al (2021) fda approval summary: enfortumab vedotin for locally advanced or metastatic urothelial carcinoma FDA approval summary: enfortumab vedotin. Clin Cancer Res 27:922\u2013927","journal-title":"Clin Cancer Res"},{"key":"5144_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1397-002x.2001.10994.x","volume":"59","author":"Y Chen","year":"2002","unstructured":"Chen Y, Mant C, Hodges R (2002) Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic \u03b1-helix. J Pept Res 59:18\u201333","journal-title":"J Pept Res"},{"key":"5144_CR33","doi-asserted-by":"publisher","first-page":"12316","DOI":"10.1074\/jbc.M413406200","volume":"280","author":"Y Chen","year":"2005","unstructured":"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS (2005) Rational design of \u03b1-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index. J Biol Chem 280:12316\u201312329","journal-title":"J Biol Chem"},{"key":"5144_CR34","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.peptides.2010.05.010","volume":"31","author":"YQ Chen","year":"2010","unstructured":"Chen YQ, Min C, Sang M, Han YY, Ma X, Xue XQ, Zhang SQ (2010) A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells. Peptides 31:1504\u20131510","journal-title":"Peptides"},{"key":"5144_CR35","doi-asserted-by":"publisher","first-page":"31899","DOI":"10.1038\/srep31899","volume":"6","author":"L Chen","year":"2016","unstructured":"Chen L, Cohen J, Song X, Zhao A, Ye Z, Feulner CJ, Doonan P, Somers W, Lin L et al (2016) Improved variants of SrtA for site-specific conjugation on antibodies and proteins with high efficiency. Sci Rep 6:31899","journal-title":"Sci Rep"},{"key":"5144_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-017-0356-6","volume":"24","author":"Y-T Chin","year":"2017","unstructured":"Chin Y-T, Wang L-M, Hsieh M-T, Shih Y-J, Nana AW, Changou CA, Yang Y-CS, Chiu H-C, Fu E et al (2017) Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells. J Biomed Sci 24:1\u201313","journal-title":"J Biomed Sci"},{"key":"5144_CR37","doi-asserted-by":"publisher","first-page":"e0190638","DOI":"10.1371\/journal.pone.0190638","volume":"13","author":"YJ Choi","year":"2018","unstructured":"Choi YJ, Park SJ, Park YS, Park HS, Yang KM, Heo K (2018) EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells. PLoS ONE 13:e0190638. https:\/\/doi.org\/10.1371\/journal.pone.0190638","journal-title":"PLoS ONE"},{"key":"5144_CR38","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1021\/bi800223y","volume":"47","author":"ML Colgrave","year":"2008","unstructured":"Colgrave ML, Kotze AC, Huang YH, O\u2019Grady J, Simonsen SM, Craik DJ (2008) Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry 47:5581\u20135589. https:\/\/doi.org\/10.1021\/bi800223y","journal-title":"Biochemistry"},{"key":"5144_CR39","doi-asserted-by":"publisher","first-page":"9046","DOI":"10.1039\/C8CS00573G","volume":"47","author":"AC Conibear","year":"2018","unstructured":"Conibear AC, Watson EE, Payne RJ, Becker CF (2018) Native chemical ligation in protein synthesis and semi-synthesis. Chem Soc Rev 47:9046\u20139068","journal-title":"Chem Soc Rev"},{"key":"5144_CR40","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2174\/0929867325666171123204851","volume":"27","author":"AC Conibear","year":"2020","unstructured":"Conibear AC, Schmid A, Kamalov M, Becker CF, Bello C (2020) Recent advances in peptide-based approaches for cancer treatment. Curr Med Chem 27:1174\u20131205","journal-title":"Curr Med Chem"},{"key":"5144_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4155\/tde.12.75","volume":"3","author":"JE Constance","year":"2012","unstructured":"Constance JE, Lim CS (2012) Targeting malignant mitochondria with therapeutic peptides. Ther Deliv 3:961\u2013979. https:\/\/doi.org\/10.4155\/tde.12.75","journal-title":"Ther Deliv"},{"key":"5144_CR42","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1039\/D0CS00556H","volume":"50","author":"BM Cooper","year":"2021","unstructured":"Cooper BM, Iegre J, O\u2019Donovan DH, Halvarsson M\u00d6, Spring DR (2021) Peptides as a platform for targeted therapeutics for cancer: peptide\u2013drug conjugates (PDCs). Chem Soc Rev 50:1480\u20131494","journal-title":"Chem Soc Rev"},{"key":"5144_CR43","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1021\/nn4057269","volume":"8","author":"DM Copolovici","year":"2014","unstructured":"Copolovici DM, Langel K, Eriste E, Langel U (2014) Cell-penetrating peptides: design, synthesis, and applications. ACS Nano 8:1972\u20131994","journal-title":"ACS Nano"},{"key":"5144_CR44","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/annonc\/mdm058","volume":"18","author":"D Cornelio","year":"2007","unstructured":"Cornelio D, Roesler R, Schwartsmann G (2007) Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol 18:1457\u20131466","journal-title":"Ann Oncol"},{"key":"5144_CR45","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cbin.11137","volume":"43","author":"MS D\u2019arcy","year":"2019","unstructured":"D\u2019arcy MS (2019) Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 43:582\u2013592","journal-title":"Cell Biol Int"},{"key":"5144_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.127920","volume":"40","author":"CC Dai","year":"2021","unstructured":"Dai CC, Huang W, Yang J, Hussein WM, Wang J, Khalil ZG, Capon RJ, Toth I, Stephenson RJ (2021) Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines. Bioorg Med Chem Lett 40:127920","journal-title":"Bioorg Med Chem Lett"},{"key":"5144_CR47","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2174\/1871520614666140825110001","volume":"14","author":"A Darabi","year":"2014","unstructured":"Darabi A, Thuring C, Paulsson KM (2014) HLA-I antigen presentation and tapasin influence immune responses against malignant brain tumors\u2013considerations for successful immunotherapy. Anti-Cancer Agents Med Chem (formerly Current Medicinal Chemistry-Anti-Cancer Agents) 14:1094\u20131100","journal-title":"Anti-Cancer Agents Med Chem (formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"key":"5144_CR48","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/17474124.2019.1685381","volume":"13","author":"S Das","year":"2019","unstructured":"Das S, Al-Toubah T, El-Haddad G, Strosberg J (2019) 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol 13:1023\u20131031","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"5144_CR49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/psc.491","volume":"9","author":"JS Davies","year":"2003","unstructured":"Davies JS (2003) The cyclization of peptides and depsipeptides. J Pept Sci 9:471\u2013501","journal-title":"J Pept Sci"},{"key":"5144_CR50","first-page":"241","volume":"44","author":"K Davitt","year":"2014","unstructured":"Davitt K, Babcock BD, Fenelus M, Poon CK, Sarkar A, Trivigno V, Zolkind PA, Matthew SM, Grin\u2019kina N et al (2014) The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells. Ann Clin Lab Sci 44:241\u2013248","journal-title":"Ann Clin Lab Sci"},{"key":"5144_CR51","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/molecules27031075","volume":"27","author":"BG de la Torre","year":"2022","unstructured":"de la Torre BG, Albericio F (2022) The pharmaceutical industry in 2021. An analysis of FDA drug approvals from the perspective of molecules. Molecules 27:1075. https:\/\/doi.org\/10.3390\/molecules27031075","journal-title":"Molecules"},{"key":"5144_CR52","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/molecules28031038","volume":"28","author":"BG de la Torre","year":"2023","unstructured":"de la Torre BG, Albericio F (2023) The pharmaceutical industry in 2022: an analysis of FDA drug approvals from the perspective of molecules. Molecules 28:1038. https:\/\/doi.org\/10.3390\/molecules28031038","journal-title":"Molecules"},{"key":"5144_CR53","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s40265-019-01175-0","volume":"79","author":"ED Deeks","year":"2019","unstructured":"Deeks ED (2019) Polatuzumab vedotin: first global approval. Drugs 79:1467\u20131475","journal-title":"Drugs"},{"key":"5144_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/cbdd.12667","volume":"87","author":"X Deng","year":"2016","unstructured":"Deng X, Qiu Q, Wang X, Huang W, Qian H (2016) Design, synthesis, and biological evaluation of novel cholesteryl peptides with anticancer and multidrug resistance-reversing activities. Chem Biol Drug Des 87:374\u2013381","journal-title":"Chem Biol Drug Des"},{"key":"5144_CR55","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bpc.2006.12.009","volume":"127","author":"SR Dennison","year":"2007","unstructured":"Dennison SR, Harris F, Phoenix DA (2007) The interactions of aurein 1.2 with cancer cell membranes. Biophys Chem 127:78\u201383. https:\/\/doi.org\/10.1016\/j.bpc.2006.12.009","journal-title":"Biophys Chem"},{"key":"5144_CR56","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40265-021-01522-0","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S (2021) Melphalan flufenamide (Melflufen): first approval. Drugs 81:963\u2013969","journal-title":"Drugs"},{"key":"5144_CR57","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40265-022-01704-4","volume":"82","author":"S Dhillon","year":"2022","unstructured":"Dhillon S (2022) Tebentafusp: first approval. Drugs 82:703\u2013710","journal-title":"Drugs"},{"key":"5144_CR58","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","volume":"17","author":"L Di","year":"2015","unstructured":"Di L (2015) Strategic approaches to optimizing peptide ADME properties. AAPS J 17:134\u2013143","journal-title":"AAPS J"},{"key":"5144_CR59","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/jamaoncol.2017.5597","volume":"4","author":"F Dossa","year":"2018","unstructured":"Dossa F, Acuna SA, Rickles AS, Berho M, Wexner SD, Quereshy FA, Baxter NN, Chadi SA (2018) Association between adjuvant chemotherapy and overall survival in patients with rectal cancer and pathological complete response after neoadjuvant chemotherapy and resection. JAMA Oncol 4:930\u2013937","journal-title":"JAMA Oncol"},{"key":"5144_CR60","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.3390\/ijms22168677","volume":"22","author":"N Doti","year":"2021","unstructured":"Doti N, Mardirossian M, Sandomenico A, Ruvo M, Caporale A (2021) Recent applications of retro-inverso peptides. Int J Mol Sci 22:8677","journal-title":"Int J Mol Sci"},{"key":"5144_CR61","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1391972","volume":"7","author":"V Dutoit","year":"2018","unstructured":"Dutoit V, Migliorini D, Ranzanici G, Marinari E, Widmer V, Lobrinus JA, Momjian S, Costello J, Walker PR et al (2018) Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma. Oncoimmunology 7:e1391972","journal-title":"Oncoimmunology"},{"key":"5144_CR62","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/12469","volume":"5","author":"HM Ellerby","year":"1999","unstructured":"Ellerby HM, Arap W, Ellerby LM, Kain R, Andrusiak R, Rio GD, Krajewski S, Lombardo CR, Rao R et al (1999) Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 5:1032\u20131038","journal-title":"Nat Med"},{"key":"5144_CR63","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1038\/s41467-020-17736-x","volume":"11","author":"Y Engelberg","year":"2020","unstructured":"Engelberg Y, Landau M (2020) The Human LL-37 (17\u201329) antimicrobial peptide reveals a functional supramolecular structure. Nat Commun 11:3894","journal-title":"Nat Commun"},{"key":"5144_CR64","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1039\/D2MA00082B","volume":"3","author":"X Fan","year":"2022","unstructured":"Fan X, Wang T, Han M, Gu Y, Sun G, Peng X, Shou Q, Song H, Liu W et al (2022) Dual CEA\/CD44 targeting to colorectal cancer cells using nanobody-conjugated hyaluronic acid-modified mesoporous silica nanoparticles with pH-and redox-sensitivity. Mater Adv 3:4707\u20134717","journal-title":"Mater Adv"},{"key":"5144_CR65","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1007\/s13277-015-3719-1","volume":"36","author":"S Farsinejad","year":"2015","unstructured":"Farsinejad S, Gheisary Z, Ebrahimi Samani S, Alizadeh AM (2015) Mitochondrial targeted peptides for cancer therapy. Tumour Biol 36:5715\u20135725. https:\/\/doi.org\/10.1007\/s13277-015-3719-1","journal-title":"Tumour Biol"},{"key":"5144_CR66","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 149:778\u2013789","journal-title":"Int J Cancer"},{"key":"5144_CR67","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/foods12020253","volume":"12","author":"RL Ferrero","year":"2023","unstructured":"Ferrero RL, Weinstein-Oppenheimer CR, Cabrera-Mu\u00f1oz Z, Z\u00fa\u00f1iga-Hansen ME (2023) The antiproliferative activity of a mixture of peptide and oligosaccharide extracts obtained from defatted rapeseed meal on breast cancer cells and human fibroblasts. Foods 12:253","journal-title":"Foods"},{"key":"5144_CR68","unstructured":"Food, D Administration, F approves lutetium Lu (2018) 177 dotatate for treatment of GEP-NETS. Accessed 26 Jan"},{"key":"5144_CR69","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","volume":"20","author":"K Fosgerau","year":"2015","unstructured":"Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20:122\u2013128. https:\/\/doi.org\/10.1016\/j.drudis.2014.10.003","journal-title":"Drug Discov Today"},{"key":"5144_CR70","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.apsb.2022.07.020","volume":"13","author":"C Fu","year":"2022","unstructured":"Fu C, Yu L, Miao Y, Liu X, Yu Z, Wei M (2022) Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope? Acta Pharm Sin B 13:498\u2013516","journal-title":"Acta Pharm Sin B"},{"key":"5144_CR71","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbamcr.2014.11.006","volume":"1853","author":"D Gaspar","year":"2015","unstructured":"Gaspar D, Freire JM, Pacheco TR, Barata JT, Castanho MA (2015) Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics. Biochim Biophys Acta 1853:308\u2013316. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.11.006","journal-title":"Biochim Biophys Acta"},{"key":"5144_CR72","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1517\/13543784.2015.1065250","volume":"24","author":"M Gentile","year":"2015","unstructured":"Gentile M, Offidani M, Vigna E, Corvatta L, Recchia AG, Morabito L, Morabito F, Gentili S (2015) Ixazomib for the treatment of multiple myeloma. Expert Opin Investig Drugs 24:1287\u20131298","journal-title":"Expert Opin Investig Drugs"},{"key":"5144_CR73","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4155\/fmc.14.125","volume":"6","author":"C Ginn","year":"2014","unstructured":"Ginn C, Khalili H, Lever R, Brocchini S (2014) PEGylation and its impact on the design of new protein-based medicines. Future Med Chem 6:1829\u20131846","journal-title":"Future Med Chem"},{"key":"5144_CR74","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12072-009-9132-3","volume":"3","author":"RG Gish","year":"2009","unstructured":"Gish RG, Gordon SC, Nelson D, Rustgi V, Rios I (2009) A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma. Hepatol Int 3:480\u2013489","journal-title":"Hepatol Int"},{"key":"5144_CR75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jcp.10456","volume":"199","author":"S Glover","year":"2004","unstructured":"Glover S, Delaney M, Dematte C, Kornberg L, Frasco M, Tran-Son-Tay R, Benya RV (2004) Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin-releasing peptide\u2019s morphogenic properties. J Cell Physiol 199:77\u201388","journal-title":"J Cell Physiol"},{"key":"5144_CR76","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/ijms21051682","volume":"21","author":"M Gomes-Porras","year":"2020","unstructured":"Gomes-Porras M, Cardenas-Salas J, Alvarez-Escola C (2020) Somatostatin analogs in clinical practice: a review. Int J Mol Sci 21:1682. https:\/\/doi.org\/10.3390\/ijms21051682","journal-title":"Int J Mol Sci"},{"key":"5144_CR77","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.3077","volume-title":"Phase Ia study of CBP-1008, a bi-specific ligand drug conjugate targeting FR\u03b1 and TRPV6, in patients with advanced solid tumors","author":"J Gong","year":"2021","unstructured":"Gong J, Hu X, Zhang J, Du Y, Huang R, Teng Y, Tan W, Shen L (2021) Phase Ia study of CBP-1008, a bi-specific ligand drug conjugate targeting FR\u03b1 and TRPV6, in patients with advanced solid tumors. Wolters Kluwer Health, Philadelphia"},{"key":"5144_CR78","doi-asserted-by":"publisher","first-page":"103362","DOI":"10.1016\/j.jddst.2022.103362","volume":"72","author":"AO Gonz\u00e1lez-Cruz","year":"2022","unstructured":"Gonz\u00e1lez-Cruz AO, Hern\u00e1ndez-Ju\u00e1rez J, Ram\u00edrez-Cabrera MA, Balderas-Renter\u00eda I, Arredondo-Espinoza E (2022) Peptide-based drug-delivery systems: a new hope for improving cancer therapy. J Drug Deliv Sci Technol 72:103362. https:\/\/doi.org\/10.1016\/j.jddst.2022.103362","journal-title":"J Drug Deliv Sci Technol"},{"key":"5144_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-019-4007-6","volume":"25","author":"F Grisoni","year":"2019","unstructured":"Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G (2019) De novo design of anticancer peptides by ensemble artificial neural networks. J Mol Model 25:1\u201310","journal-title":"J Mol Model"},{"key":"5144_CR80","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/toxins14070438","volume":"14","author":"R Guo","year":"2022","unstructured":"Guo R, Liu J, Chai J, Gao Y, Abdel-Rahman MA, Xu X (2022) Scorpion peptide Smp24 exhibits a potent antitumor effect on human lung cancer cells by damaging the membrane and cytoskeleton in vivo and in vitro. Toxins (basel) 14:438","journal-title":"Toxins (basel)"},{"key":"5144_CR81","doi-asserted-by":"publisher","first-page":"C45","DOI":"10.1152\/ajpcell.00229.2006","volume":"292","author":"AB Gustafsson","year":"2007","unstructured":"Gustafsson AB, Gottlieb RA (2007) Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 292:C45\u2013C51. https:\/\/doi.org\/10.1152\/ajpcell.00229.2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"5144_CR82","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.26717\/BJSTR.2018.08.001694","volume":"8","author":"YA Haggag","year":"2018","unstructured":"Haggag YA, Donia AA, Osman MA, El-Gizawy SA (2018) Peptides as drug candidates: limitations and recent development perspectives. Biomed J 8:6659\u20136662.  \nhttps:\/\/doi.org\/10.26717\/BJSTR.2018.08.001694","journal-title":"Biomed J"},{"key":"5144_CR83","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1021\/bm500246w","volume":"15","author":"IW Hamley","year":"2014","unstructured":"Hamley IW (2014) PEG\u2013peptide conjugates. Biomacromol 15:1543\u20131559","journal-title":"Biomacromol"},{"key":"5144_CR84","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.bcp.2013.08.008","volume":"86","author":"Y-Y Han","year":"2013","unstructured":"Han Y-Y, Liu H-Y, Han D-J, Zong X-C, Zhang S-Q, Chen Y-Q (2013) Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells. Biochem Pharmacol 86:1254\u20131262","journal-title":"Biochem Pharmacol"},{"key":"5144_CR85","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"5144_CR86","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214\u2013221","journal-title":"Nat Rev Drug Discov"},{"key":"5144_CR87","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1039\/D1OB00411E","volume":"19","author":"HC Hayes","year":"2021","unstructured":"Hayes HC, Luk LY, Tsai Y-H (2021) Approaches for peptide and protein cyclisation. Org Biomol Chem 19:3983\u20134001","journal-title":"Org Biomol Chem"},{"key":"5144_CR88","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41586-021-04232-5","volume":"601","author":"JS Heitmann","year":"2022","unstructured":"Heitmann JS, Bilich T, Tandler C, Nelde A, Maringer Y, Marconato M, Reusch J, J\u00e4ger S, Denk M et al (2022) A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity. Nature 601:617","journal-title":"Nature"},{"key":"5144_CR89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/ph13030038","volume":"13","author":"U Hennrich","year":"2020","unstructured":"Hennrich U, Bene\u0161ov\u00e1 M (2020) [68Ga] Ga-DOTA-TOC: the first FDA-approved 68Ga-radiopharmaceutical for PET imaging. Pharmaceuticals 13:38","journal-title":"Pharmaceuticals"},{"key":"5144_CR90","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1158\/1078-0432.CCR-13-0755","volume":"19","author":"TM Herndon","year":"2013","unstructured":"Herndon TM, Deisseroth A, Kaminskas E, Kane RC, Koti KM, Rothmann MD, Habtemariam B, Bullock J, Bray JD et al (2013) US Food and Drug Administration Approval: carfilzomib for the treatment of multiple myeloma FDA approval summary of carfilzomib. Clin Cancer Res 19:4559\u20134563","journal-title":"Clin Cancer Res"},{"key":"5144_CR91","doi-asserted-by":"publisher","unstructured":"Hicks RP, AL Russell (2012) Application of unnatural amino acids to the de novo design of selective antibiotic peptides. Unnatl Amino Acids Methods Protoc 794:135\u2013167. https:\/\/doi.org\/10.1007\/978-1-61779-331-8_9","DOI":"10.1007\/978-1-61779-331-8_9"},{"key":"5144_CR92","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.yexmp.2013.07.006","volume":"95","author":"AL Hilchie","year":"2013","unstructured":"Hilchie AL, Vale R, Zemlak TS, Hoskin DW (2013) Generation of a hematologic malignancy-selective membranolytic peptide from the antimicrobial core (RRWQWR) of bovine lactoferricin. Exp Mol Pathol 95:192\u2013198. https:\/\/doi.org\/10.1016\/j.yexmp.2013.07.006","journal-title":"Exp Mol Pathol"},{"key":"5144_CR93","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1016\/j.bbamem.2016.09.021","volume":"1858","author":"AL Hilchie","year":"2016","unstructured":"Hilchie AL, Sharon AJ, Haney EF, Hoskin DW, Bally MB, Franco OL, Corcoran JA, Hancock RE (2016) Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma. Biochim Biophys Acta (BBA) Biomembr 1858:3195\u20133204","journal-title":"Biochim Biophys Acta (BBA) Biomembr"},{"key":"5144_CR94","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","volume":"1778","author":"DW Hoskin","year":"2008","unstructured":"Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778:357\u2013375. https:\/\/doi.org\/10.1016\/j.bbamem.2007.11.008","journal-title":"Biochim Biophys Acta"},{"key":"5144_CR95","first-page":"4059","volume":"8","author":"E Hu","year":"2015","unstructured":"Hu E, Wang D, Chen J, Tao X (2015) Novel cyclotides from Hedyotis diffusa induce apoptosis and inhibit proliferation and migration of prostate cancer cells. Int J Clin Exp Med 8:4059\u20134065","journal-title":"Int J Clin Exp Med"},{"key":"5144_CR96","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13238-010-0004-3","volume":"1","author":"Y Huang","year":"2010","unstructured":"Huang Y, Huang J, Chen Y (2010) Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell 1:143\u2013152. https:\/\/doi.org\/10.1007\/s13238-010-0004-3","journal-title":"Protein Cell"},{"key":"5144_CR97","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejphar.2014.07.053","volume":"741","author":"MH Imanieh","year":"2014","unstructured":"Imanieh MH, Bagheri F, Alizadeh AM, Ashkani-Esfahani S (2014) Oxytocin has therapeutic effects on cancer, a hypothesis. Eur J Pharmacol 741:112\u2013123","journal-title":"Eur J Pharmacol"},{"key":"5144_CR98","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1078-0432.Ccr-13-1560","volume":"20","author":"TZ Iversen","year":"2014","unstructured":"Iversen TZ, Engell-Noerregaard L, Ellebaek E, Andersen R, Larsen SK, Bjoern J, Zeyher C, Gouttefangeas C, Thomsen BM et al (2014) Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase. Clin Cancer Res 20:221\u2013232. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-1560","journal-title":"Clin Cancer Res"},{"key":"5144_CR99","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","volume":"121","author":"M Izci","year":"2021","unstructured":"Izci M, Maksoudian C, Manshian BB, Soenen SJ (2021) The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem Rev 121:1746\u20131803. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00779","journal-title":"Chem Rev"},{"key":"5144_CR100","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/cdd.2008.179","volume":"16","author":"AM Jabbour","year":"2009","unstructured":"Jabbour AM, Heraud JE, Daunt CP, Kaufmann T, Sandow J, O\u2019Reilly LA, Callus BA, Lopez A, Strasser A et al (2009) Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim. Cell Death Differ 16:555\u2013563. https:\/\/doi.org\/10.1038\/cdd.2008.179","journal-title":"Cell Death Differ"},{"key":"5144_CR101","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1749-6632.1999.tb07919.x","volume":"887","author":"E Jacotot","year":"1999","unstructured":"Jacotot E, Costantini P, Laboureau E, Zamzami N, Susin SA, Kroemer G (1999) Mitochondrial membrane permeabilization during the apoptotic process. Ann N Y Acad Sci 887:18\u201330. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb07919.x","journal-title":"Ann N Y Acad Sci"},{"key":"5144_CR102","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.gene.2018.12.065","volume":"692","author":"H Jeon","year":"2019","unstructured":"Jeon H, Le MT, Ahn B, Cho HS, Le VCQ, Yum J, Hong K, Kim JH, Song H et al (2019) Copy number variation of PR-39 cathelicidin, and identification of PR-35, a natural variant of PR-39 with reduced mammalian cytotoxicity. Gene 692:88\u201393. https:\/\/doi.org\/10.1016\/j.gene.2018.12.065","journal-title":"Gene"},{"key":"5144_CR103","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/MPG.0000000000000481","volume":"59","author":"R Jiang","year":"2014","unstructured":"Jiang R, Du X, L\u00f6nnerdal B (2014) Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. J Pediatr Gastroenterol Nutr 59:642\u2013652","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5144_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-022-01274-8","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Huang W, Sun X, Yang X, Wu Y, Shi J, Zheng J, Fan S, Liu J et al (2022) DTX-P7, a peptide\u2013drug conjugate, is highly effective for non-small cell lung cancer. J Hematol Oncol 15:1\u20138","journal-title":"J Hematol Oncol"},{"key":"5144_CR105","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/bjh.15207","volume":"181","author":"JJ Jimenez","year":"2018","unstructured":"Jimenez JJ, DelCanto GM, Popovics P, Perez A, Vila Granda A, Vidaurre I, Cai RZ, Rick FG, Swords RT et al (2018) A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone. Br J Haematol 181:476\u2013485","journal-title":"Br J Haematol"},{"key":"5144_CR106","doi-asserted-by":"publisher","first-page":"12394","DOI":"10.1038\/ncomms12394","volume":"7","author":"K Jin","year":"2016","unstructured":"Jin K, Sam IH, Po KHL, Da Lin EH, Ghazvini Zadeh S, Chen YY, Li X (2016) Total synthesis of teixobactin. Nat Commun 7:12394","journal-title":"Nat Commun"},{"key":"5144_CR107","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1021\/acsnano.7b08148","volume":"12","author":"H Jin","year":"2018","unstructured":"Jin H, Wan C, Zou Z, Zhao G, Zhang L, Geng Y, Chen T, Huang A, Jiang F et al (2018) Tumor ablation and therapeutic immunity induction by an injectable peptide hydrogel. ACS Nano 12:3295\u20133310","journal-title":"ACS Nano"},{"key":"5144_CR108","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/molecules26072059","volume":"26","author":"X Ju","year":"2021","unstructured":"Ju X, Fan D, Kong L, Yang Q, Zhu Y, Zhang S, Su G, Li Y (2021) Antimicrobial peptide Brevinin-1RL1 from frog skin secretion induces apoptosis and necrosis of tumor cells. Molecules 26:2059","journal-title":"Molecules"},{"key":"5144_CR109","first-page":"1","volume":"2011","author":"D Kakde","year":"2011","unstructured":"Kakde D, Jain D, Shrivastava V, Kakde R, Patil A (2011) Cancer therapeutics-opportunities, challenges and advances in drug delivery. J Appl Pharm Sci 2011:1\u201310","journal-title":"J Appl Pharm Sci"},{"key":"5144_CR110","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/jcb.21712","volume":"104","author":"ED Karagiannis","year":"2008","unstructured":"Karagiannis ED, Popel AS (2008) Novel anti-angiogenic peptides derived From ELR-containing CXC chemokines. J Cell Biochem 104:1356\u20131363","journal-title":"J Cell Biochem"},{"key":"5144_CR111","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1016\/j.bmcl.2006.07.026","volume":"16","author":"N Kawanishi","year":"2006","unstructured":"Kawanishi N, Sugimoto T, Shibata J, Nakamura K, Masutani K, Ikuta M, Hirai H (2006) Structure-based drug design of a highly potent CDK1, 2, 4, 6 inhibitor with novel macrocyclic quinoxalin-2-one structure. Bioorg Med Chem Lett 16:5122\u20135126","journal-title":"Bioorg Med Chem Lett"},{"key":"5144_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2018.01.133","volume":"499","author":"O Khamessi","year":"2018","unstructured":"Khamessi O, Ben Mabrouk H, ElFessi-Magouri R, Kharrat R (2018) RK1, the first very short peptide from Buthus occitanus tunetanus inhibits tumor cell migration, proliferation and angiogenesis. Biochem Biophys Res Commun 499:1\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.133","journal-title":"Biochem Biophys Res Commun"},{"key":"5144_CR113","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2014.12.018","volume":"201","author":"IA Khawar","year":"2015","unstructured":"Khawar IA, Kim JH, Kuh H-J (2015) Improving drug delivery to solid tumors: priming the tumor microenvironment. J Controll Rel 201:78\u201389","journal-title":"J Controll Rel"},{"key":"5144_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-016-0160-y","volume":"4","author":"H Khong","year":"2016","unstructured":"Khong H, Overwijk WW (2016) Adjuvants for peptide-based cancer vaccines. J Immunother Cancer 4:1\u201311","journal-title":"J Immunother Cancer"},{"key":"5144_CR115","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13550-022-00891-1","volume":"12","author":"F Kind","year":"2022","unstructured":"Kind F, Michalski K, Yousefzadeh-Nowshahr E, Meyer PT, Mix M, Ruf J (2022) Bone marrow impairment during early [177Lu] PSMA-617 radioligand therapy: haematotoxicity or tumour progression? EJNMMI Res 12:20","journal-title":"EJNMMI Res"},{"key":"5144_CR116","doi-asserted-by":"publisher","first-page":"2209304","DOI":"10.1002\/adfm.202209304","volume":"33","author":"P Koirala","year":"2023","unstructured":"Koirala P, Chen SPR, Boer JC, Khalil ZG, Deceneux C, Goodchild G, Lu L, Faruck MO, Shalash AO et al (2023) Polymeric nanoparticles as a self-adjuvanting peptide vaccine delivery system: the role of shape. Adv Funct Mater 33:2209304","journal-title":"Adv Funct Mater"},{"key":"5144_CR117","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","volume":"192","author":"A Kolate","year":"2014","unstructured":"Kolate A, Baradia D, Patil S, Vhora I, Kore G, Misra A (2014) PEG\u2014a versatile conjugating ligand for drugs and drug delivery systems. J Controll Rel 192:67\u201381","journal-title":"J Controll Rel"},{"key":"5144_CR118","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/cas.14909","volume":"112","author":"E Kondo","year":"2021","unstructured":"Kondo E, Iioka H, Saito K (2021) Tumor-homing peptide and its utility for advanced cancer medicine. Cancer Sci 112:2118\u20132125","journal-title":"Cancer Sci"},{"key":"5144_CR119","doi-asserted-by":"publisher","unstructured":"Kordi M, Borzouyi Z, Chitsaz S, Asmaei M, Salami R, Tabarzad M (2022) Antimicrobial peptides with anticancer activity: today status, trends and their computational design. Arch Biochem Biophys 1:109484. https:\/\/doi.org\/10.1016\/j.abb.2022.109484","DOI":"10.1016\/j.abb.2022.109484"},{"key":"5144_CR120","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bmc.2004.09.009","volume":"13","author":"JA Kritzer","year":"2005","unstructured":"Kritzer JA, Stephens OM, Guarracino DA, Reznik SK, Schepartz A (2005) \u03b2-Peptides as inhibitors of protein\u2013protein interactions. Biorg Med Chem 13:11\u201316","journal-title":"Biorg Med Chem"},{"key":"5144_CR121","first-page":"1","volume":"41","author":"A Kumar","year":"2022","unstructured":"Kumar A, Sharma P, Arun A, Meena LS (2022) Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against Mycobacterium tuberculosis H37Rv: an immuno-informatics approach. J Biomol Struct Dyn 41:1\u201323","journal-title":"J Biomol Struct Dyn"},{"key":"5144_CR122","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coph.2019.01.008","volume":"47","author":"K Kurrikoff","year":"2019","unstructured":"Kurrikoff K, Aphkhazava D, Langel \u00dc (2019) The future of peptides in cancer treatment. Curr Opin Pharm 47:27\u201332","journal-title":"Curr Opin Pharm"},{"key":"5144_CR123","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1039\/c0ib00013b","volume":"2","author":"P Laakkonen","year":"2010","unstructured":"Laakkonen P, Vuorinen K (2010) Homing peptides as targeted delivery vehicles. Integr Biol 2:326\u2013337","journal-title":"Integr Biol"},{"key":"5144_CR124","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.bmc.2017.08.052","volume":"26","author":"V Le Joncour","year":"2018","unstructured":"Le Joncour V, Laakkonen P (2018) Seek & Destroy, use of targeting peptides for cancer detection and drug delivery. Biorg Med Chem 26:2797\u20132806","journal-title":"Biorg Med Chem"},{"key":"5144_CR125","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40265-021-01550-w","volume":"81","author":"A Lee","year":"2021","unstructured":"Lee A (2021) Loncastuximab tesirine: first approval. Drugs 81:1229\u20131233","journal-title":"Drugs"},{"key":"5144_CR126","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.eururo.2005.12.043","volume":"50","author":"J Lehmann","year":"2006","unstructured":"Lehmann J, Retz M, Sidhu SS, Suttmann H, Sell M, Paulsen F, Harder J, Unteregger G, St\u00f6ckle M (2006) Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Eur Urol 50:141\u2013147. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.043","journal-title":"Eur Urol"},{"key":"5144_CR127","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pharmthera.2017.10.010","volume":"183","author":"ML Leite","year":"2018","unstructured":"Leite ML, da Cunha NB, Costa FF (2018) Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment. Pharmacol Ther 183:160\u2013176","journal-title":"Pharmacol Ther"},{"key":"5144_CR128","doi-asserted-by":"publisher","first-page":"2200213","DOI":"10.1002\/gch2.202200213","volume":"7","author":"T Lerksuthirat","year":"2023","unstructured":"Lerksuthirat T, On-yam P, Chitphuk S, Stitchantrakul W, Newburg DS, Morrow AL, Hongeng S, Chiangjong W, Chutipongtanate S (2023) ALA-A2 is a novel anticancer peptide inspired by alpha-lactalbumin: a discovery from a computational peptide library, in silico anticancer peptide screening and in vitro experimental validation. Glob Chall 7:2200213","journal-title":"Glob Chall"},{"key":"5144_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-10-S1-S1","volume":"10","author":"ZJ Li","year":"2012","unstructured":"Li ZJ, Cho CH (2012) Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery. J Transl Med 10:1\u20139","journal-title":"J Transl Med"},{"key":"5144_CR130","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1074-5521(03)00047-4","volume":"10","author":"S Li","year":"2003","unstructured":"Li S, Roberts RW (2003) A novel strategy for in vitro selection of peptide-drug conjugates. Chem Biol 10:233\u2013239","journal-title":"Chem Biol"},{"key":"5144_CR131","first-page":"1","volume-title":"Targeting metastatic breast cancer with ANG1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (BBB)","author":"F Li","year":"2017","unstructured":"Li F, Tang S-C (2017) Targeting metastatic breast cancer with ANG1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (BBB), vol 4. Elsevier, Oxford, pp 1\u20133"},{"key":"5144_CR132","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3892\/mmr.2012.968","volume":"5","author":"M Li","year":"2012","unstructured":"Li M, Shi HS, Zhang HL, Luo ZC, Wan Y, Lu L, Luo S-T, Yang L (2012) bFGF peptide combined with the pVAX-8CpG plasmid as adjuvant is a novel anticancer vaccine inducing effective immune responses against Lewis lung carcinoma. Mol Med Report 5:625\u2013630","journal-title":"Mol Med Report"},{"key":"5144_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201900610","author":"C Li","year":"2019","unstructured":"Li C, Zhao Y, Cheng J, Guo J, Zhang Q, Zhang X, Ren J, Wang F, Huang J et al (2019) A proresolving peptide nanotherapy for site-specific treatment of inflammatory bowel disease by regulating proinflammatory microenvironment and gut microbiota. Adv Sci. https:\/\/doi.org\/10.1002\/advs.201900610","journal-title":"Adv Sci"},{"key":"5144_CR134","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.3390\/molecules26196042","volume":"26","author":"J Lindberg","year":"2021","unstructured":"Lindberg J, Nilvebrant J, Nygren P-\u00c5, Lehmann F (2021) Progress and future directions with peptide-drug conjugates for targeted cancer therapy. Molecules 26:6042","journal-title":"Molecules"},{"key":"5144_CR135","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-030-58174-9_2","volume-title":"Bio-nanomedicine for cancer therapy","author":"P Lingasamy","year":"2021","unstructured":"Lingasamy P, Teesalu T (2021) Homing peptides for cancer therapy. Bio-nanomedicine for cancer therapy. Springer, Cham, pp 29\u201348"},{"key":"5144_CR136","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1021\/jm501514h","volume":"58","author":"T-Y Liu","year":"2015","unstructured":"Liu T-Y, Hussein WM, Giddam AK, Jia Z, Reiman JM, Zaman M, McMillan NA, Good MF, Monteiro MJ et al (2015) Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccine. J Med Chem 58:888\u2013896","journal-title":"J Med Chem"},{"key":"5144_CR137","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1021\/acs.jmedchem.1c02022","volume":"65","author":"N Liu","year":"2022","unstructured":"Liu N, Zhang Y, Lei Y, Wang R, Zhan M, Liu J, An Y, Zhou Y, Zhan J et al (2022) Design and evaluation of a novel peptide\u2013drug conjugate covalently targeting SARS-CoV-2 papain-like protease. J Med Chem 65:876\u2013884","journal-title":"J Med Chem"},{"key":"5144_CR138","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/RLU.0000000000002578","volume":"44","author":"T Long","year":"2019","unstructured":"Long T, Yang N, Zhou M, Chen D, Li Y, Li J, Tang Y, Liu Z, Li Z et al (2019) Clinical application of 18F-AlF-NOTA-octreotide PET\/CT in combination with 18F-FDG PET\/CT for imaging neuroendocrine neoplasms. Clin Nucl Med 44:452\u2013458","journal-title":"Clin Nucl Med"},{"key":"5144_CR139","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77:1745\u20131770","journal-title":"Cell Mol Life Sci"},{"key":"5144_CR140","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1021\/acs.chemrev.0c00963","volume":"121","author":"S Lv","year":"2021","unstructured":"Lv S, Sylvestre M, Prossnitz AN, Yang LF, Pun SH (2021) Design of polymeric carriers for intracellular peptide delivery in oncology applications. Chem Rev 121:11653\u201311698","journal-title":"Chem Rev"},{"key":"5144_CR141","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1517\/13543784.15.8.933","volume":"15","author":"JS Mader","year":"2006","unstructured":"Mader JS, Hoskin DW (2006) Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 15:933\u2013946","journal-title":"Expert Opin Investig Drugs"},{"key":"5144_CR142","first-page":"1404","volume":"11","author":"B Mahalaksmi","year":"2023","unstructured":"Mahalaksmi B, Nandhini J (2023) An overview of various cancer treatments of melanoma and its diagnosis. J Coast Life Med 11:1404\u20131420","journal-title":"J Coast Life Med"},{"key":"5144_CR143","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1038\/s41598-022-06429-8","volume":"12","author":"VS Maia","year":"2022","unstructured":"Maia VS, Berzaghi R, Arruda DC, Machado FC, Loureiro LL, Melo PM, Morais AS, Budu A, Travassos LR (2022) PLP2-derived peptide Rb4 triggers PARP-1-mediated necrotic death in murine melanoma cells. Sci Rep 12:2890","journal-title":"Sci Rep"},{"key":"5144_CR144","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jbiotec.2004.03.015","volume":"112","author":"M Malesevic","year":"2004","unstructured":"Malesevic M, Strijowski U, B\u00e4chle D, Sewald N (2004) An improved method for the solution cyclization of peptides under pseudo-high dilution conditions. J Biotechnol 112:73\u201377","journal-title":"J Biotechnol"},{"key":"5144_CR145","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.4161\/cbt.209","volume":"2","author":"MK Manion","year":"2003","unstructured":"Manion MK, Hockenbery DM (2003) Targeting BCL-2-related proteins in cancer therapy. Cancer Biol Ther 2:S105-114","journal-title":"Cancer Biol Ther"},{"key":"5144_CR146","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B (2017) The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 7:339\u2013348. https:\/\/doi.org\/10.15171\/apb.2017.041","journal-title":"Adv Pharm Bull"},{"key":"5144_CR147","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","volume":"6","author":"MT Manzari","year":"2021","unstructured":"Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA (2021) Targeted drug delivery strategies for precision medicines. Nat Rev Mater 6:351\u2013370","journal-title":"Nat Rev Mater"},{"key":"5144_CR148","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s40265-021-01633-8","volume":"81","author":"A Markham","year":"2021","unstructured":"Markham A (2021) Tisotumab vedotin: first approval. Drugs 81:2141\u20132147","journal-title":"Drugs"},{"key":"5144_CR149","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1529\/biophysj.107.104026","volume":"92","author":"D Marsh","year":"2007","unstructured":"Marsh D, Jost M, Peggion C, Toniolo C (2007) Lipid chain-length dependence for incorporation of alamethicin in membranes: electron paramagnetic resonance studies on TOAC-spin labeled analogs. Biophys J 92:4002\u20134011. https:\/\/doi.org\/10.1529\/biophysj.107.104026","journal-title":"Biophys J"},{"key":"5144_CR150","doi-asserted-by":"publisher","first-page":"213403","DOI":"10.1155\/2012\/213403","volume":"2012","author":"C Martel","year":"2012","unstructured":"Martel C, Huynhle H, Garnier A, Ventura-Clapier R, Brenner C (2012) Inhibition of the mitochondrial permeability transition for cytoprotection: direct versus indirect mechanisms. Biochem Res Int 2012:213403. https:\/\/doi.org\/10.1155\/2012\/213403","journal-title":"Biochem Res Int"},{"key":"5144_CR151","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.devcel.2011.06.017","volume":"21","author":"JC Martinou","year":"2011","unstructured":"Martinou JC, Youle RJ (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21:92\u2013101. https:\/\/doi.org\/10.1016\/j.devcel.2011.06.017","journal-title":"Dev Cell"},{"key":"5144_CR152","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.3390\/jcm9103120","volume":"9","author":"M-V Mateos","year":"2020","unstructured":"Mateos M-V, Blad\u00e9 J, Bringhen S, Ocio EM, Efebera Y, Pour L, Gay F, Sonneveld P, Gullbo J et al (2020) Melflufen: a peptide\u2013drug conjugate for the treatment of multiple myeloma. J Clin Med 9:3120","journal-title":"J Clin Med"},{"key":"5144_CR153","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/cas.13522","volume":"109","author":"S Matsueda","year":"2018","unstructured":"Matsueda S, Itoh K, Shichijo S (2018) Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase. Cancer Sci 109:611\u2013617","journal-title":"Cancer Sci"},{"key":"5144_CR154","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.omto.2019.05.002","volume":"14","author":"B Mauseth","year":"2019","unstructured":"Mauseth B, Camilio KA, Shi J, Hammarstr\u00f6m CL, Rekdal \u00d8, Sveinbj\u00f8rnsson B, Line P-D (2019) The novel oncolytic compound LTX-401 induces antitumor immune responses in experimental hepatocellular carcinoma. Mo Ther Oncolyt 14:139\u2013148","journal-title":"Mo Ther Oncolyt"},{"key":"5144_CR155","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1586\/era.09.69","volume":"9","author":"PA Meyers","year":"2009","unstructured":"Meyers PA (2009) Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma. Expert Rev Anticancer Ther 9:1035\u20131049","journal-title":"Expert Rev Anticancer Ther"},{"key":"5144_CR156","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/138920012798356934","volume":"13","author":"P Milla","year":"2012","unstructured":"Milla P, Dosio F, Cattel L (2012) PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr Drug Metab 13:105\u2013119","journal-title":"Curr Drug Metab"},{"key":"5144_CR157","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1158\/1078-0432.CCR-18-2867","volume":"25","author":"EA Mittendorf","year":"2019","unstructured":"Mittendorf EA, Lu B, Melisko M, Price Hiller J, Bondarenko I, Brunt AM, Sergii G, Petrakova K, Peoples GE (2019) Efficacy and safety analysis of nelipepimut-S vaccine to prevent breast cancer recurrence: a randomized, multicenter, phase III clinical trial randomized phase III trial of nelipepimut-S in breast cancer. Clin Cancer Res 25:4248\u20134254","journal-title":"Clin Cancer Res"},{"key":"5144_CR158","first-page":"14","volume":"28","author":"D Mochly-Rosen","year":"2010","unstructured":"Mochly-Rosen D, Qvit N (2010) Peptide inhibitors of protein-protein interactions. Chim Oggi\/chem Today 28:14\u201316","journal-title":"Chim Oggi\/chem Today"},{"key":"5144_CR159","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1039\/d2bm01715f","volume":"11","author":"A Mohapatra","year":"2023","unstructured":"Mohapatra A, Rajendrakumar SK, Cherukula K, Park MS, Padmanaban S, Vasukuty A, Mohanty A, Lee JY, Bae WK et al (2023) A sugar modified amphiphilic cationic nano-adjuvant ceased tumor immune suppression and rejuvenated peptide vaccine induced antitumor immunity in cervical cancer. Biomater Sci 11:1853\u20131866. https:\/\/doi.org\/10.1039\/d2bm01715f","journal-title":"Biomater Sci"},{"key":"5144_CR160","doi-asserted-by":"publisher","unstructured":"Motavalli Khiavi F, Arashkia A, Golkar M, Nasimi M, Roohvand F, Azadmanesh K (2018) A dual-type L2 11\u201388 peptide from HPV types 16\/18 formulated in Montanide ISA 720 induced strong and balanced Th1\/Th2 immune responses, associated with high titers of broad spectrum cross-reactive antibodies in vaccinated mice. J Immunol Res 2018:9464186. https:\/\/doi.org\/10.1155\/2018\/9464186","DOI":"10.1155\/2018\/9464186"},{"key":"5144_CR161","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler M, King GF, Adams DJ, Alewood PF (2021) Trends in peptide drug discovery. Nat Rev Drug Discovery 20:309\u2013325","journal-title":"Nat Rev Drug Discovery"},{"key":"5144_CR162","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/neuonc\/noy200","volume":"21","author":"Y Narita","year":"2019","unstructured":"Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y et al (2019) A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma. Neuro Oncol 21:348\u2013359","journal-title":"Neuro Oncol"},{"key":"5144_CR163","doi-asserted-by":"publisher","first-page":"1000022","DOI":"10.1074\/mcp.R120.002309","volume":"20","author":"A Nelde","year":"2021","unstructured":"Nelde A, Rammensee H-G, Walz JS (2021) The peptide vaccine of the future. Mol Cell Proteom 20:1000022","journal-title":"Mol Cell Proteom"},{"key":"5144_CR164","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10863-006-9060-z","volume":"39","author":"J Neuzil","year":"2007","unstructured":"Neuzil J, Dyason JC, Freeman R, Dong L-F, Prochazka L, Wang X-F, Scheffler I, Ralph SJ (2007) Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J Bioenerg Biomembr 39:65\u201372","journal-title":"J Bioenerg Biomembr"},{"key":"5144_CR165","doi-asserted-by":"publisher","unstructured":"Nguyen KT (2011) Targeted nanoparticles for cancer therapy: promises and challenge. J Nanomedic Nanotechnol 2:1000103e. https:\/\/doi.org\/10.4172\/2157-7439.1000103e","DOI":"10.4172\/2157-7439.1000103e"},{"key":"5144_CR166","doi-asserted-by":"publisher","first-page":"19512","DOI":"10.1073\/pnas.0709443104","volume":"104","author":"M Nguyen","year":"2007","unstructured":"Nguyen M, Marcellus RC, Roulston A, Watson M, Serfass L, Murthy Madiraju SR, Goulet D, Viallet J, Belec L et al (2007) Small molecule obatoclax (GX15\u2013070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc Natl Acad Sci USA 104:19512\u201319517. https:\/\/doi.org\/10.1073\/pnas.0709443104","journal-title":"Proc Natl Acad Sci USA"},{"key":"5144_CR167","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3892\/or.2020.7847","volume":"45","author":"M Noguchi","year":"2021","unstructured":"Noguchi M, Fujimoto K, Arai G, Uemura H, Hashine K, Matsumoto H, Fukasawa S, Kohjimoto Y, Nakatsu H et al (2021) A randomized phase III trial of personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel. Oncol Rep 45:159\u2013168","journal-title":"Oncol Rep"},{"key":"5144_CR168","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/cdd.2008.123","volume":"15","author":"E Norberg","year":"2008","unstructured":"Norberg E, Gogvadze V, Ott M, Horn M, Uhlen P, Orrenius S, Zhivotovsky B (2008) An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ 15:1857\u20131864","journal-title":"Cell Death Differ"},{"key":"5144_CR169","doi-asserted-by":"publisher","first-page":"198","DOI":"10.31989\/ffhd.v12i4.904","volume":"12","author":"R Nurdiani","year":"2022","unstructured":"Nurdiani R, Vasiljevic T, Singh TK, Donkor ON, Prihanto AA, Kusuma TS (2022) Stability of an anticancer peptide isolated from Flathead by-products during in vitro gastrointestinal digestion. Funct Foods Health Dis 12:198\u2013207","journal-title":"Funct Foods Health Dis"},{"key":"5144_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-59745-419-3_1","volume":"494","author":"L Otvos Jr","year":"2008","unstructured":"Otvos L Jr (2008) Peptide-based drug design: here and now. Methods Mol Biol 494:1\u20138. https:\/\/doi.org\/10.1007\/978-1-59745-419-3_1","journal-title":"Methods Mol Biol"},{"key":"5144_CR171","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/19336918.2021.1951425","volume":"15","author":"J-B Oudart","year":"2021","unstructured":"Oudart J-B, Villemin M, Brassart B, Sellier C, Terryn C, Dupont-Deshorgue A, Monboisse JC, Maquart F-X, Ramont L et al (2021) F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through \u03b1v\u03b23 and \u03b15\u03b21 integrin interaction. Cell Adh Migr 15:215\u2013223","journal-title":"Cell Adh Migr"},{"key":"5144_CR172","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/cmar.s232708","volume":"12","author":"X Pan","year":"2020","unstructured":"Pan X, Xu J, Jia X (2020) Research progress evaluating the function and mechanism of anti-tumor peptides. Cancer Manag Res 12:397\u2013409. https:\/\/doi.org\/10.2147\/cmar.s232708","journal-title":"Cancer Manag Res"},{"key":"5144_CR173","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.progpolymsci.2007.05.008","volume":"32","author":"G Pasut","year":"2007","unstructured":"Pasut G, Veronese F (2007) Polymer\u2013drug conjugation, recent achievements and general strategies. Prog Polym Sci 32:933\u2013961","journal-title":"Prog Polym Sci"},{"key":"5144_CR174","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1039\/D0NJ04134C","volume":"45","author":"TK Patel","year":"2021","unstructured":"Patel TK, Adhikari N, Amin SA, Biswas S, Jha T, Ghosh B (2021) Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery. New J Chem 45:5291\u20135321","journal-title":"New J Chem"},{"key":"5144_CR175","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.biochi.2022.06.011","volume":"201","author":"SM Patil","year":"2022","unstructured":"Patil SM, Kunda NK (2022) Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC). Biochimie 201:7\u201317","journal-title":"Biochimie"},{"key":"5144_CR176","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00726-017-2509-z","volume":"50","author":"X Peng","year":"2018","unstructured":"Peng X, Zhou C, Hou X, Liu Y, Wang Z, Peng X, Zhang Z, Wang R, Kong D (2018) Molecular characterization and bioactivity evaluation of two novel bombinin peptides from the skin secretion of Oriental fire-bellied toad, Bombina orientalis. Amino Acids 50:241\u2013253. https:\/\/doi.org\/10.1007\/s00726-017-2509-z","journal-title":"Amino Acids"},{"key":"5144_CR177","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/biomedicines11010043","volume":"11","author":"GV P\u00e9rez","year":"2023","unstructured":"P\u00e9rez GV, Rosales M, Ram\u00f3n AC, Rodr\u00edguez-Ulloa A, Besada V, Gonz\u00e1lez LJ, Aguilar D, V\u00e1zquez-Blomquist D, Falc\u00f3n V et al (2023) CIGB-300 anticancer peptide differentially interacts with CK2 subunits and regulates specific signaling mediators in a highly sensitive large cell lung carcinoma cell model. Biomedicines 11:43","journal-title":"Biomedicines"},{"key":"5144_CR178","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1128\/AAC.06330-11","volume":"56","author":"F Pouillot","year":"2012","unstructured":"Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P, Bingen E, Bonacorsi S (2012) Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b: H4-ST131 Escherichia coli strain producing CTX-M-15. Antimicrob Agents Chemother 56:3568\u20133575","journal-title":"Antimicrob Agents Chemother"},{"key":"5144_CR180","unstructured":"Raedler LA Padcev (Enfortumab Vedotin-ejfv) FDA approved for the treatment of Metastatic Urothelial Carcinoma. Available online: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-regular-approval-enfortumab-vedotin-ejfv-locally-advanced-or-metastatic-urothelial-cancer"},{"key":"5144_CR181","doi-asserted-by":"publisher","first-page":"101169","DOI":"10.1016\/j.imu.2023.101169","volume":"37","author":"MM Rahman","year":"2023","unstructured":"Rahman MM, Masum MHU, Talukder A, Akter R (2023) An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers. Inform Med Unlock 37:101169","journal-title":"Inform Med Unlock"},{"key":"5144_CR182","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/B978-0-12-824147-9.00007-8","volume-title":"Fundamentals of bionanomaterials","author":"S Rahmani","year":"2022","unstructured":"Rahmani S, Maroufkhani M, Mohammadzadeh-Komuleh S, Khoubi-Arani Z (2022) Polymer nanocomposites for biomedical applications. Fundamentals of bionanomaterials. Elsevier, Oxford, pp 175\u2013215"},{"key":"5144_CR183","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.euf.2017.09.009","volume":"5","author":"S Rausch","year":"2019","unstructured":"Rausch S, Gouttefangeas C, Hennenlotter J, Laske K, Walter K, Feyerabend S, Chandran PA, Kruck S, Singh-Jasuja H et al (2019) Results of a phase 1\/2 study in metastatic renal cell carcinoma patients treated with a patient-specific adjuvant multi-peptide vaccine after resection of metastases. Eur Urol Focus 5:604\u2013607","journal-title":"Eur Urol Focus"},{"key":"5144_CR184","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10495-018-1485-4","volume":"23","author":"T Ray","year":"2018","unstructured":"Ray T, Kar D, Pal A, Mukherjee S, Das C, Pal A (2018) Molecular targeting of breast and colon cancer cells by PAR1 mediated apoptosis through a novel pro-apoptotic peptide. Apoptosis 23:679\u2013694","journal-title":"Apoptosis"},{"key":"5144_CR185","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/bjp.2008.260","volume":"155","author":"A Regina","year":"2008","unstructured":"Regina A, Demeule M, Che C, Lavallee I, Poirier J, Gabathuler R, B\u00e9liveau R, Castaigne JP (2008) Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol 155:185\u2013197","journal-title":"Br J Pharmacol"},{"key":"5144_CR186","doi-asserted-by":"publisher","first-page":"e63641","DOI":"10.1371\/journal.pone.0063641","volume":"8","author":"SX Ren","year":"2013","unstructured":"Ren SX, Shen J, Cheng AS, Lu L, Chan RL, Li ZJ, Wang XJ, Wong CC, Zhang L et al (2013) FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS ONE 8:e63641. https:\/\/doi.org\/10.1371\/journal.pone.0063641","journal-title":"PLoS ONE"},{"key":"5144_CR187","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","volume":"447","author":"J Renukuntla","year":"2013","unstructured":"Renukuntla J, Vadlapudi AD, Patel A, Boddu SH, Mitra AK (2013) Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 447:75\u201393","journal-title":"Int J Pharm"},{"key":"5144_CR188","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3389\/fimmu.2017.01320","volume":"8","author":"R Roudi","year":"2017","unstructured":"Roudi R, Syn NL, Roudbary M (2017) Antimicrobial peptides as biologic and immunotherapeutic agents against cancer: a comprehensive overview. Front Immunol 8:1320. https:\/\/doi.org\/10.3389\/fimmu.2017.01320","journal-title":"Front Immunol"},{"key":"5144_CR189","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.chemphyslip.2011.09.003","volume":"164","author":"AL Russell","year":"2011","unstructured":"Russell AL, Kennedy AM, Spuches AM, Gibson WS, Venugopal D, Klapper D, Srouji AH, Bhonsle JB, Hicks RP (2011) Determining the effect of the incorporation of unnatural amino acids into antimicrobial peptides on the interactions with zwitterionic and anionic membrane model systems. Chem Phys Lipids 164:740\u2013758","journal-title":"Chem Phys Lipids"},{"key":"5144_CR190","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1021\/acs.jmedchem.7b01837","volume":"61","author":"AF Salem","year":"2018","unstructured":"Salem AF, Wang S, Billet S, Chen J-F, Udompholkul P, Gambini L, Baggio C, Tseng H-R, Posadas EM et al (2018) Reduction of circulating cancer cells and metastases in breast-cancer models by a potent EphA2-agonistic peptide\u2013drug conjugate. J Med Chem 61:2052\u20132061","journal-title":"J Med Chem"},{"key":"5144_CR191","first-page":"327","volume":"8","author":"U Sandler","year":"2010","unstructured":"Sandler U, Devary O, Braitbard O, Ohana J, Kass G, Rubinstein AM, Friedman ZY, Devary Y (2010) NEROFE\u2014a novel human hormone-peptide with anti-cancer activity. J Exp Ther Oncol 8:327\u2013339","journal-title":"J Exp Ther Oncol"},{"key":"5144_CR192","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/biomedicines10050945","volume":"10","author":"E Sarafraz-Yazdi","year":"2022","unstructured":"Sarafraz-Yazdi E, Mumin S, Cheung D, Fridman D, Lin B, Wong L, Rosal R, Rudolph R, Frenkel M et al (2022) PNC-27, a chimeric p53-penetratin peptide binds to HDM-2 in a p53 peptide-like structure, induces selective membrane-pore formation and leads to cancer cell lysis. Biomedicines 10:945","journal-title":"Biomedicines"},{"key":"5144_CR193","doi-asserted-by":"publisher","first-page":"CT108","DOI":"10.1158\/1538-7445.AM2022-CT108","volume":"82","author":"M Saxena","year":"2022","unstructured":"Saxena M, Burke A, Pavlick A, Blazquez A, Gimenez G, Meseck M, Donovan M, Rodriguez D, Castillo-Martin M et al (2022) Abstract CT108: immunogenicity of poly-ICLC matured dendritic cells as an adjuvant for NY-ESO-1 and Melan-A-MART-1 peptide vaccination compared to Montanide\u00ae ISA-51 VG, in study subjects with melanoma in complete clinical remission but at high risk of disease recurrence. Cancer Res 82:CT108\u2013CT108","journal-title":"Cancer Res"},{"key":"5144_CR194","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001157","author":"J Schuhmacher","year":"2020","unstructured":"Schuhmacher J, Heidu S, Balchen T, Richardson JR, Schmeltz C, Sonne J, Schweiker J, Rammensee HG, Thor Straten P et al (2020) Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I\/II clinical trial. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001157","journal-title":"J Immunother Cancer"},{"key":"5144_CR195","doi-asserted-by":"publisher","first-page":"13638","DOI":"10.1073\/pnas.96.24.13638","volume":"96","author":"CP Scott","year":"1999","unstructured":"Scott CP, Abel-Santos E, Wall M, Wahnon DC, Benkovic SJ (1999) Production of cyclic peptides and proteins in vivo. Proc Natl Acad Sci 96:13638\u201313643","journal-title":"Proc Natl Acad Sci"},{"key":"5144_CR196","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/molecules28030930","volume":"28","author":"K Selvarathinam","year":"2023","unstructured":"Selvarathinam K, Subramani P, Thekkumalai M, Vilwanathan R, Selvarajan R, Abia ALK (2023) Wnt signaling pathway collapse upon \u03b2-catenin destruction by a novel antimicrobial peptide SKACP003: unveiling the molecular mechanism and genetic activities using breast cancer cell lines. Molecules 28:930","journal-title":"Molecules"},{"key":"5144_CR197","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1158\/0008-5472.CAN-09-0349","volume":"69","author":"Y-W Seo","year":"2009","unstructured":"Seo Y-W, Woo H-N, Piya S, Moon AR, Oh J-W, Yun C-W, Kim K-K, Min J-Y, Jeong S-Y et al (2009) The cell death\u2013inducing activity of the peptide containing Noxa mitochondrial-targeting domain Is associated with calcium release. Cancer Res 69:8356\u20138365","journal-title":"Cancer Res"},{"key":"5144_CR198","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1021\/jacs.2c00452","volume":"144","author":"N Shao","year":"2022","unstructured":"Shao N, Yuan L, Ma P, Zhou M, Xiao X, Cong Z, Wu Y, Xiao G, Fei J et al (2022) Heterochiral \u03b2-peptide polymers combating multidrug-resistant cancers effectively without inducing drug resistance. J Am Chem Soc 144:7283\u20137294","journal-title":"J Am Chem Soc"},{"key":"5144_CR199","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1111\/cas.14106","volume":"110","author":"H Shima","year":"2019","unstructured":"Shima H, Tsurita G, Wada S, Hirohashi Y, Yasui H, Hayashi H, Miyakoshi T, Watanabe K, Murai A et al (2019) Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma. Cancer Sci 110:2378\u20132385","journal-title":"Cancer Sci"},{"key":"5144_CR200","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4103\/1735-5362.327503","volume":"16","author":"A Shoari","year":"2021","unstructured":"Shoari A, Khodabakhsh F, Cohan RA, Salimian M, Karami E (2021) Anti-angiogenic peptides application in cancer therapy; a review. Res Pharm Sci 16:559\u2013574","journal-title":"Res Pharm Sci"},{"key":"5144_CR201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162318","volume":"11","author":"M Si","year":"2016","unstructured":"Si M, Xu Q, Jiang L, Huang H (2016) SpyTag\/SpyCatcher cyclization enhances the thermostability of firefly luciferase. PLoS ONE 11:e0162318","journal-title":"PLoS ONE"},{"key":"5144_CR202","first-page":"11","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal AA (2013) Analysis of fiducials implanted during EUS for patients with localized rectal cancer receiving high-dose rate endorectal brachytherapy. Gastrointest Endosc 63:11\u201330","journal-title":"Gastrointest Endosc"},{"key":"5144_CR203","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348","journal-title":"CA Cancer J Clin"},{"key":"5144_CR204","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12033-019-00156-8","volume":"61","author":"M Sioud","year":"2019","unstructured":"Sioud M (2019) Phage display libraries: from binders to targeted drug delivery and human therapeutics. Mol Biotechnol 61:286\u2013303. https:\/\/doi.org\/10.1007\/s12033-019-00156-8","journal-title":"Mol Biotechnol"},{"key":"5144_CR205","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.1021\/jo0620056","volume":"71","author":"MB Soellner","year":"2006","unstructured":"Soellner MB, Tam A, Raines RT (2006) Staudinger ligation of peptides at non-glycyl residues. J Org Chem 71:9824\u20139830","journal-title":"J Org Chem"},{"key":"5144_CR206","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0304-3835(99)00044-0","volume":"139","author":"M Sok","year":"1999","unstructured":"Sok M, \u0160entjurc M, Schara M (1999) Membrane fluidity characteristics of human lung cancer. Cancer Lett 139:215\u2013220","journal-title":"Cancer Lett"},{"key":"5144_CR207","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2174\/0929866527666200409102747","volume":"27","author":"TN Soon","year":"2020","unstructured":"Soon TN, Chia AY, Yap WH, Tang Y-Q (2020) Anticancer mechanisms of bioactive peptides. Protein Pept Lett 27:823\u2013830","journal-title":"Protein Pept Lett"},{"key":"5144_CR208","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/ijc.25192","volume":"127","author":"S Sotomayor","year":"2010","unstructured":"Sotomayor S, Mu\u00f1oz-Moreno L, Carmena MJ, Schally AV, S\u00e1nchez-Chapado M, Prieto JC, Bajo AM (2010) Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095). Int J Cancer 127:1813\u20131822","journal-title":"Int J Cancer"},{"key":"5144_CR209","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, Dayton BD, Ding H, Enschede SH et al (2013) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202\u2013208","journal-title":"Nat Med"},{"key":"5144_CR210","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/1078-0432.CCR-20-3435","volume":"27","author":"J Spicer","year":"2021","unstructured":"Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jossang DE, Awada A, Kristeleit R, Loirat D, Lazaridis G et al (2021) Safety, antitumor activity, and T-cell responses in a dose-ranging phase I trial of the oncolytic peptide LTX-315 in patients with solid tumors. Clin Cancer Res 27:2755\u20132763. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3435","journal-title":"Clin Cancer Res"},{"key":"5144_CR211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2329-6798.1000e103","volume":"1","author":"L Sun","year":"2013","unstructured":"Sun L (2013) Peptide-based drug development. Mod Chem Appl 1:1\u20132","journal-title":"Mod Chem Appl"},{"key":"5144_CR212","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"5144_CR213","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1124\/pr.54.1.101","volume":"54","author":"A Szewczyk","year":"2002","unstructured":"Szewczyk A, Wojtczak L (2002) Mitochondria as a pharmacological target. Pharmacol Rev 54:101\u2013127","journal-title":"Pharmacol Rev"},{"key":"5144_CR214","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/0929866523666161220111833","volume":"24","author":"S Talebi","year":"2017","unstructured":"Talebi S, Bolhassani A, Azad TM, Arashkia A, Modaresi MH (2017) Immuno-stimulating peptide derived from HMGB1 is more effective than the N-terminal domain of Gp96 as an endogenous adjuvant for improvement of protein vaccines. Protein Pept Lett 24:190\u2013196","journal-title":"Protein Pept Lett"},{"key":"5144_CR215","doi-asserted-by":"publisher","first-page":"10803","DOI":"10.3390\/molecules190810803","volume":"19","author":"J Tan","year":"2014","unstructured":"Tan J, Huang J, Huang Y, Chen Y (2014) Effects of single amino acid substitution on the biophysical properties and biological activities of an amphipathic \u03b1-helical antibacterial peptide against Gram-negative bacteria. Molecules 19:10803\u201310817","journal-title":"Molecules"},{"key":"5144_CR216","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1039\/D0SC02023K","volume":"11","author":"TS Tang","year":"2020","unstructured":"Tang TS, Cardella D, Lander AJ, Li X, Escudero JS, Tsai Y-H, Luk LY (2020) Use of an asparaginyl endopeptidase for chemo-enzymatic peptide and protein labeling. Chem Sci 11:5881\u20135888","journal-title":"Chem Sci"},{"key":"5144_CR217","doi-asserted-by":"publisher","first-page":"2062982","DOI":"10.1080\/21645515.2022.2062982","volume":"18","author":"M Tang","year":"2022","unstructured":"Tang M, Cai J-H, Diao H-Y, Guo W-M, Yang X, Xing S (2022) The progress of peptide vaccine clinical trials in gynecologic oncology. Hum Vaccin Immunother 18:2062982","journal-title":"Hum Vaccin Immunother"},{"key":"5144_CR218","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1021\/la034197v","volume":"19","author":"S Terrettaz","year":"2003","unstructured":"Terrettaz S, Mayer M, Vogel H (2003) Highly electrically insulating tethered lipid bilayers for probing the function of ion channel proteins. Langmuir 19:5567\u20135569. https:\/\/doi.org\/10.1021\/la034197v","journal-title":"Langmuir"},{"key":"5144_CR219","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s11095-009-9964-5","volume":"26","author":"FC Thomas","year":"2009","unstructured":"Thomas FC, Taskar K, Rudraraju V, Goda S, Thorsheim HR, Gaasch JA, Mittapalli RK, Palmieri D, Steeg PS et al (2009) Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm Res 26:2486\u20132494","journal-title":"Pharm Res"},{"key":"5144_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-01769-3","volume":"11","author":"PB Timmons","year":"2021","unstructured":"Timmons PB, Hewage CM (2021) Conformation and membrane interaction studies of the potent antimicrobial and anticancer peptide palustrin-Ca. Sci Rep 11:1\u201313","journal-title":"Sci Rep"},{"key":"5144_CR221","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25122850","author":"AL Tornesello","year":"2020","unstructured":"Tornesello AL, Borrelli A, Buonaguro L, Buonaguro FM, Tornesello ML (2020) Antimicrobial peptides as anticancer agents: functional properties and biological activities. Molecules. https:\/\/doi.org\/10.3390\/molecules25122850","journal-title":"Molecules"},{"key":"5144_CR222","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/cbic.201000451","volume":"12","author":"J Touati","year":"2011","unstructured":"Touati J, Angelini A, Hinner MJ, Heinis C (2011) Enzymatic cyclisation of peptides with a transglutaminase. ChemBioChem 12:38\u201342","journal-title":"ChemBioChem"},{"key":"5144_CR223","doi-asserted-by":"publisher","first-page":"D837","DOI":"10.1093\/nar\/gku892","volume":"43","author":"A Tyagi","year":"2015","unstructured":"Tyagi A, Tuknait A, Anand P, Gupta S, Sharma M, Mathur D, Joshi A, Singh S, Gautam A et al (2015) CancerPPD: a database of anticancer peptides and proteins. Nucleic Acids Res 43:D837\u2013D843","journal-title":"Nucleic Acids Res"},{"key":"5144_CR224","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-66095-0_8","volume-title":"Peptides and peptide-based biomaterials and their biomedical applications","author":"KR Ulapane","year":"2017","unstructured":"Ulapane KR, Kopec BM, Moral ME, Siahaan TJ (2017) Peptides and drug delivery. Peptides and peptide-based biomaterials and their biomedical applications. Springer, Berlin, pp 167\u2013184"},{"key":"5144_CR225","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/138161210789941847","volume":"16","author":"A Urruticoechea","year":"2010","unstructured":"Urruticoechea A, Alemany R, Balart J, Villanueva A, Vinals F, Capella G (2010) Recent advances in cancer therapy: an overview. Curr Pharm Des 16:3\u201310","journal-title":"Curr Pharm Des"},{"key":"5144_CR226","doi-asserted-by":"publisher","first-page":"e0181748","DOI":"10.1371\/journal.pone.0181748","volume":"12","author":"SS Usmani","year":"2017","unstructured":"Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, Ahuja AA, Sharma M, Gautam A et al (2017) THPdb: database of FDA-approved peptide and protein therapeutics. PLoS ONE 12:e0181748. https:\/\/doi.org\/10.1371\/journal.pone.0181748","journal-title":"PLoS ONE"},{"key":"5144_CR227","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.peptides.2003.12.006","volume":"25","author":"MI van der Kraan","year":"2004","unstructured":"van der Kraan MI, Groenink J, Nazmi K, Veerman EC, Bolscher JG, Nieuw Amerongen AV (2004) Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25:177\u2013183. https:\/\/doi.org\/10.1016\/j.peptides.2003.12.006","journal-title":"Peptides"},{"key":"5144_CR228","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10989-022-10395-0","volume":"28","author":"M Velayutham","year":"2022","unstructured":"Velayutham M, Guru A, Gatasheh MK, Hatamleh AA, Juliet A, Arockiaraj J (2022) Molecular docking of SA11, RF13 and DI14 peptides from vacuolar protein sorting associated protein 26B against cancer proteins and in vitro investigation of its anticancer potency in Hep-2 cells. Int J Pept Res Ther 28:87","journal-title":"Int J Pept Res Ther"},{"key":"5144_CR229","doi-asserted-by":"publisher","first-page":"e95939","DOI":"10.1371\/journal.pone.0095939","volume":"9","author":"EJ Veldhuizen","year":"2014","unstructured":"Veldhuizen EJ, Schneider VA, Agustiandari H, van Dijk A, Tjeerdsma-van Bokhoven JL, Bikker FJ, Haagsman HP (2014) Antimicrobial and immunomodulatory activities of PR-39 derived peptides. PLoS ONE 9:e95939. https:\/\/doi.org\/10.1371\/journal.pone.0095939","journal-title":"PLoS ONE"},{"key":"5144_CR230","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1016\/j.bmc.2010.05.065","volume":"18","author":"D Venugopal","year":"2010","unstructured":"Venugopal D, Klapper D, Srouji AH, Bhonsle JB, Borschel R, Mueller A, Russell AL, Williams BC, Hicks RP (2010) Novel antimicrobial peptides that exhibit activity against select agents and other drug resistant bacteria. Biorg Med Chem 18:5137\u20135147","journal-title":"Biorg Med Chem"},{"key":"5144_CR231","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1016\/j.vaccine.2018.05.106","volume":"36","author":"S Verma","year":"2018","unstructured":"Verma S, Sugadev R, Kumar A, Chandna S, Ganju L, Bansal A (2018) Multi-epitope DnaK peptide vaccine against S. Typhi: an in silico approach. Vaccine 36:4014\u20134022","journal-title":"Vaccine"},{"key":"5144_CR232","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1189\/jlb.3A1015-453RRR","volume":"101","author":"AT Vieira","year":"2017","unstructured":"Vieira AT, Galv\u00e3o I, Macia LM, Sernaglia EM, Vinolo MAR, Garcia CC, Tavares LP, Amaral FA, Sousa LP et al (2017) Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice. J Leukocyte Biol 101:275\u2013284. https:\/\/doi.org\/10.1189\/jlb.3A1015-453RRR","journal-title":"J Leukocyte Biol"},{"key":"5144_CR233","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","volume":"15","author":"P Vlieghe","year":"2010","unstructured":"Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15:40\u201356. https:\/\/doi.org\/10.1016\/j.drudis.2009.10.009","journal-title":"Drug Discov Today"},{"key":"5144_CR234","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1126\/science.1099191","volume":"305","author":"LD Walensky","year":"2004","unstructured":"Walensky LD, Kung AL, Escher I, Malia TJ, Barbuto S, Wright RD, Wagner G, Verdine GL, Korsmeyer SJ (2004) Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305:1466\u20131470","journal-title":"Science"},{"key":"5144_CR235","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.bbrc.2019.03.088","volume":"512","author":"Y Wang","year":"2019","unstructured":"Wang Y, Guo D, He J, Song L, Chen H, Zhang Z, Tan N (2019) Inhibition of fatty acid synthesis arrests colorectal neoplasm growth and metastasis: anti-cancer therapeutical effects of natural cyclopeptide RA-XII. Biochem Biophys Res Commun 512:819\u2013824. https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.088","journal-title":"Biochem Biophys Res Commun"},{"key":"5144_CR236","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s10989-021-10253-5","volume":"27","author":"C Wang","year":"2021","unstructured":"Wang C, Huang L, Li R, Wang Y, Wu X, Shang D (2021a) Synergistic therapy of doxorubicin with cationic anticancer peptide L-K6 reverses multidrug resistance in MCF-7\/ADR cancer cells in vitro via P-glycoprotein inhibition. Int J Pept Res Ther 27:2291\u20132301","journal-title":"Int J Pept Res Ther"},{"key":"5144_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121139","volume":"278","author":"M-D Wang","year":"2021","unstructured":"Wang M-D, Hou D-Y, Lv G-T, Li R-X, Hu X-J, Wang Z-J, Zhang N-Y, Yi L, Xu W-H et al (2021b) Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency. Biomaterials 278:121139","journal-title":"Biomaterials"},{"key":"5144_CR238","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/acs.chemrev.0c00383","volume":"121","author":"RA Ward","year":"2020","unstructured":"Ward RA, Fawell S, Floc\u2019h N, Flemington V, McKerrecher D, Smith PD (2020) Challenges and opportunities in cancer drug resistance. Chem Rev 121:3297\u20133351","journal-title":"Chem Rev"},{"key":"5144_CR239","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1021\/acs.jmedchem.8b02036","volume":"62","author":"BH White","year":"2019","unstructured":"White BH, Whalen K, Kriksciukaite K, Alargova R, Au Yeung T, Bazinet P, Brockman A, DuPont M, Oller H et al (2019) Discovery of an SSTR2-targeting maytansinoid conjugate (PEN-221) with potent activity in vitro and in vivo. J Med Chem 62:2708\u20132719","journal-title":"J Med Chem"},{"key":"5144_CR240","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","volume":"28","author":"SJ Whittaker","year":"2010","unstructured":"Whittaker SJ, Demierre M-F, Kim EJ, Rook AH, Lerner A, Duvic M, Scarisbrick J, Reddy S, Robak T et al (2010) Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. J Clin Oncol 28:4485\u20134491","journal-title":"J Clin Oncol"},{"key":"5144_CR241","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1021\/jacs.5b01140","volume":"137","author":"P Wilson","year":"2015","unstructured":"Wilson P, Anastasaki A, Owen MR, Kempe K, Haddleton DM, Mann SK, Johnston AP, Quinn JF, Whittaker MR et al (2015) Organic arsenicals as efficient and highly specific linkers for protein\/peptide\u2013polymer conjugation. J Am Chem Soc 137:4215\u20134222","journal-title":"J Am Chem Soc"},{"key":"5144_CR242","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2174\/0929866525666180530122835","volume":"25","author":"H Wu","year":"2018","unstructured":"Wu H, Huang J (2018) Optimization of protein and peptide drugs based on the mechanisms of kidney clearance. Protein Pept Lett 25:514\u2013521","journal-title":"Protein Pept Lett"},{"key":"5144_CR243","unstructured":"Wu D, Zhao Y, Ren H, Si X, Zhang L, Wang C (2016) Construction of cationic anticancer peptide Temporin-1 CEa liposomes and evaluation of anti-breast cancer activity in vitro. Chin J Biochem Pharm 22\u201326"},{"key":"5144_CR244","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/md16040125","volume":"16","author":"Z-Z Wu","year":"2018","unstructured":"Wu Z-Z, Ding G-F, Huang F-F, Yang Z-S, Yu F-M, Tang Y-P, Jia Y-L, Zheng Y-Y, Chen R (2018) Anticancer activity of anthopleura anjunae oligopeptides in prostate cancer DU-145 cells. Mar Drugs 16:125","journal-title":"Mar Drugs"},{"key":"5144_CR245","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41419-018-0420-5","volume":"9","author":"X Xie","year":"2018","unstructured":"Xie X, Zhou W, Hu Y, Chen Y, Zhang H, Li Y (2018) A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity. Cell Death Dis 9:379. https:\/\/doi.org\/10.1038\/s41419-018-0420-5","journal-title":"Cell Death Dis"},{"key":"5144_CR246","doi-asserted-by":"publisher","first-page":"200004","DOI":"10.1098\/rsob.200004","volume":"10","author":"M Xie","year":"2020","unstructured":"Xie M, Liu D, Yang Y (2020a) Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open Biol 10:200004. https:\/\/doi.org\/10.1098\/rsob.200004","journal-title":"Open Biol"},{"key":"5144_CR247","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200004","volume":"10","author":"M Xie","year":"2020","unstructured":"Xie M, Liu D, Yang Y (2020b) Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open Biol 10:200004","journal-title":"Open Biol"},{"key":"5144_CR248","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/jps.20024","volume":"93","author":"B-B Yang","year":"2004","unstructured":"Yang B-B, Lum PK, Hayashi MM, Roskos LK (2004) Polyethylene glycol modification of filgrastim results in decreased renal clearance of the protein in rats. J Pharm Sci 93:1367\u20131373","journal-title":"J Pharm Sci"},{"key":"5144_CR249","doi-asserted-by":"crossref","unstructured":"Yang B, Good D, Mosaiab T (2020) Significance of LL-37 on immunomodulation and disease outcome","DOI":"10.1155\/2020\/8349712"},{"key":"5144_CR250","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.3390\/ijms23105500","volume":"23","author":"Y Yang","year":"2022","unstructured":"Yang Y, Chen H-Y, Hao H, Wang K-J (2022) The anticancer activity conferred by the mud crab antimicrobial peptide scyreprocin through apoptosis and membrane disruption. Int J Mol Sci 23:5500","journal-title":"Int J Mol Sci"},{"key":"5144_CR251","doi-asserted-by":"publisher","first-page":"1028600","DOI":"10.3389\/fonc.2022.1028600","volume":"12","author":"H Yin","year":"2022","unstructured":"Yin H, Fu X, Gao H, Gao H, Ma Y, Chen X, Zhang X, Du S-S, Qi Y-K (2022) Hybrid peptide NTP-217 triggers ROS-mediated rapid necrosis in liver cancer cells by induction of mitochondrial leakage. Front Oncol 12:1028600","journal-title":"Front Oncol"},{"key":"5144_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109740","volume":"116","author":"X Yu","year":"2023","unstructured":"Yu X, Mai Y, Wei Y, Yu N, Gao T, Yang J (2023) Therapeutic potential of tolerance-based peptide vaccines in autoimmune diseases. Int Immunopharmacol 116:109740","journal-title":"Int Immunopharmacol"},{"key":"5144_CR253","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jconrel.2019.02.016","volume":"301","author":"R Zaman","year":"2019","unstructured":"Zaman R, Islam RA, Ibnat N, Othman I, Zaini A, Lee CY, Chowdhury EH (2019) Current strategies in extending half-lives of therapeutic proteins. J Controll Rel 301:176\u2013189","journal-title":"J Controll Rel"},{"key":"5144_CR254","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/vaccines10111882","volume":"434","author":"H Zelba","year":"2022","unstructured":"Zelba H, McQueeney A, Rabsteyn A, Bartsch O, Kyzirakos C, Kayser S, Harter J, Latzer P, Hadaschik D et al (2022) Adjuvant treatment for breast cancer patients using individualized neoantigen peptide vaccination\u2014a retrospective observation. Vaccines 434:1882","journal-title":"Vaccines"},{"issue":"3","key":"5144_CR255","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/jcmm.17644","volume":"27","author":"J Zeng","year":"2023","unstructured":"Zeng J, Wang J, Wu J, Deng R, Zhang L, Chen Q, Wang J, Jin X, Gui S et al (2023) A novel antimicrobial peptide M1\u20138 targets the lysosomal pathway to inhibit autolysosome formation and promote apoptosis in liver cancer cells. J Cell Mol Med 27(3):340\u2013352","journal-title":"J Cell Mol Med"},{"key":"5144_CR256","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2011.10.023","volume":"159","author":"X-X Zhang","year":"2012","unstructured":"Zhang X-X, Eden HS, Chen X (2012) Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Controll Rel 159:2\u201313","journal-title":"J Controll Rel"},{"key":"5144_CR257","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3892\/ol.2014.2121","volume":"8","author":"G Zhang","year":"2014","unstructured":"Zhang G, Liu S, Liu Y, Wang F, Ren J, Gu J, Zhou K, Shan B (2014a) A novel cyclic pentapeptide, H-10, inhibits B16 cancer cell growth and induces cell apoptosis. Oncol Lett 8:248\u2013252. https:\/\/doi.org\/10.3892\/ol.2014.2121","journal-title":"Oncol Lett"},{"key":"5144_CR258","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1517\/17425255.2014.967679","volume":"10","author":"X Zhang","year":"2014","unstructured":"Zhang X, Wang H, Ma Z, Wu B (2014b) Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns. Expert Opin Drug Metab Toxicol 10:1691\u20131702","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5144_CR259","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molimm.2021.01.007","volume":"132","author":"J Zhang","year":"2021","unstructured":"Zhang J, Sun Y, Kang Y, Shang D (2021) Antimicrobial peptide temporin-1CEa isolated from frog skin secretions inhibits the proinflammatory response in lipopolysaccharide-stimulated RAW264. 7 murine macrophages through the MyD88-dependent signaling pathway. Mol Immunol 132:227\u2013235","journal-title":"Mol Immunol"},{"key":"5144_CR260","doi-asserted-by":"publisher","first-page":"906625","DOI":"10.3389\/fphar.2022.906625","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Chen W-Q, Zhang S-Q, Bai J-X, Lau C-L, Sze SC-W, Yung KK-L, Ko JK-S (2022) The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment. Front Pharmacol 13:906625","journal-title":"Front Pharmacol"},{"key":"5144_CR261","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.bbamem.2006.03.037","volume":"1758","author":"H Zhao","year":"2006","unstructured":"Zhao H, Sood R, Jutila A, Bose S, Fimland G, Nissen-Meyer J, Kinnunen PK (2006) Interaction of the antimicrobial peptide pheromone Plantaricin A with model membranes: implications for a novel mechanism of action. Biochim Biophys Acta 1758:1461\u20131474. https:\/\/doi.org\/10.1016\/j.bbamem.2006.03.037","journal-title":"Biochim Biophys Acta"},{"key":"5144_CR262","doi-asserted-by":"publisher","unstructured":"Zoa AB, Yang Y-j, Huang W-j, Ndoadoumgue AL, Tian Y-t (2022) The role of short peptides in tumor angiogenesis. \u8d63\u5357\u533b\u5b66\u9662\u5b66\u62a5 42:1\u201310. https:\/\/doi.org\/10.3969\/j.issn.1001-5779.2022.06.001","DOI":"10.3969\/j.issn.1001-5779.2022.06.001"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05144-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T12:04:55Z","timestamp":1698321895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05144-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":262,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["5144"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05144-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interest in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}